Xi'an Honghui Hospital
11
3
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Selective Intraperineural Nerve Root Block Study
Role: lead
Efficacy and Safety of Combination Denosumab With Eldecalcitol for Postmenopausal Women With Osteoporosis.(ESCORT)
Role: lead
Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction
Role: collaborator
Correlation Between Parameters and Prognosis of Cervical Single Open-door Surgery
Role: collaborator
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric
Role: collaborator
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
Role: collaborator
Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
Role: collaborator
A Prospective Multicenter Cohort Study About Internal Fixation Using FNS Versus MCS for Femoral Neck Fracture
Role: collaborator
Men and Women With Different Designs and Semi-individual Total Knee Replacement
Role: collaborator
Guided Cartilage Regeneration Membrane
Role: collaborator
Pre-operative Radiological Measurement to Assess Femur Rotational Alignment
Role: lead
All 11 trials loaded